Concepedia

Yiqi Su

YS

9

Publications

368

Citations

9

H-Index

2018

Active since

Affiliations

Cornell University(Current)

Memorial Sloan Kettering Cancer Center

Merck & Co., Inc., Rahway, NJ, USA (United States)

Yiqi Su is an author at Cornell University specializing in cell transplantation, blood transplantation, and marrow transplantation.

ORCID

Top concepts

Publications per year

2018–2023

9

Publications

9

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience

Andrew Lin, Molly Maloy, Yiqi Su et al. · Transplant Infectious Disease · 2019 · 81 citations · Full text

, , +17

Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study

Phaedon D. Zavras, Yiqi Su, Jiaqi Fang et al. · Biology of Blood and Marrow Transplantation · 2020 · 62 citations · Full text

A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Anat Stern, Yiqi Su, Yeon Joo Lee et al. · Biology of Blood and Marrow Transplantation · 2020 · 54 citations · Full text

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant

Susan E. Prockop, Aisha Hasan, Ekaterina Doubrovina et al. · Journal of Clinical Investigation · 2023 · 51 citations · Full text

Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort Study

Yiqi Su, Anat Stern, Eleni Karantoni et al. · Clinical Infectious Diseases · 2022 · 38 citations · Full text

Rows per page

1–5 of 9